 |
SteriGenics Acquired by IBA
 |
SteriGenics International, Inc. (NASDAQ: STER) is a leading provider of contract irradiation and sterilization services for health care and other markets |
|
TM Capital assisted SteriGenics in completing three strategic acquisitions which brought the company into new geographic markets, new sterilization technologies and new market applications |
|
TM Capital then assisted SteriGenics in completing its $214 million sale to Ion Beam Applications s.a. (BB: IBAB), a leading provider of particle accelerators for health care and other markets |
|
TM Capital also provided a fairness opinion in connection with the sale of SteriGenics to IBA |
 Client Press Release
|
MedTech Completes Recapitalization
Dinex Acquired by Carlisle Companies
Immucor Acquires BioArray Solutions
Immucor Forms Joint Venture with Kainos
Immucor Acquires Gamma Biologicals
SteriGenics Acquired by IBA
SteriGenics Acquires Nicolet from Thermo
Portland Professional Acquired by NMHC
Jensen Completes Recapitalization
Heico Sells Meditek to U.S. Diagnostic Labs
Medical Diagnostics Acquired by ANMR
Medcom Acquired by Quintiles
Armstrong Pharma Acquired by Medeva
International Murex Completes Financing
Immucor Acquires Division of Biopool
Immucor Completes Debt Restructuring
Immucor Board of Directors Re-Elected
Immucor Goodwill Valuation Analysis
SteriGenics Acquires Irradiation Industries
SteriGenics Int'l Acquires RTI
BioLok Acquired by Healthpoint Capital
